Here we discovered a novel function of the EBV miR-BHRF1-1 whereby, through inhibition of the SUMO-targeted ubiquitin ligase RNF4, the virus counteracts a cellular defense that operates during the late phase of productive infection. This evidence concerns the gene RNF4 and infection.